Precision VIR Announces Non-surgical Option for Patients with Varicose Veins

Vein expert doctors at Precision VIR in Dallas, TX announce Varithena as a non-surgical option for varicose vein patients. Sadly, vein disease does not cure itself and can get worse if untreated. Precision VIR can reduce varicose vein symptoms and improve leg appearance.

Dallas, United States - April 17, 2018 /PressCable/ —

Precision VIR Announces Availability of Varithena® as a Non-Surgical Option for Patients with Symptoms Related to or Caused by Varicose Veins

The Cutting-Edge Procedure can Reduce a Variety of Symptoms and Improve Vein Appearance

Dallas, TX (April 16, 2018) – The doctors at Precision Vascular & Interventional recently announced they incorporated Varithena® (polidocanol injectable foam) into the growing list of superior vein treatment options for their patients. Varithena is a non-surgical prescription medicine many believe can be a game-changer when it comes to treating varicose veins, specifically in combating the symptoms of heaviness, achiness, swelling, throbbing and itching.

“Precision VIR is delighted to provide patients with this non-surgical option,” Dr. Danny Chan said on behalf of himself, Dr. Jaryd Stein, and their associate vein specialists. “We have been specially trained in using Varithena. Treatment is minimally-invasive—which means no incision is required.”

Dr. Chan added, “The Varithena procedure usually takes less than one hour, and patients may resume light activities as quickly as the same day of treatment.”

More About Varicose Veins and Varithena

Varicose veins are enlarged bulging veins usually found above the surface of the skin on the legs and are a telltale sign of vein disease, where vein walls and valves have become weakened and eventually interrupt normal blood flow. These veins can range from the most common spider and varicose veins to skin breakdown and venous ulcers. More than 20 million Americans suffer from vein disease or venous disorders.

Sadly, vein disease does not cure itself and can get worse if left untreated. Luckily, there are a variety of treatment options available for patients with venous conditions, including Varithena, Sclerotherapy, ClosureFast, and Microphlebectomy.

Varithena (polidocanol injectable foam) is the latest option. It is administered through a catheter or by direct injection into the malfunctioning vein. The foam fills the desired section of the vein, and the diseased vein collapses. Blood flow then shifts to healthier veins nearby. This procedure does not require incisions. While the doctor usually numbs the injection site, no additional anesthesia is required.

Varithena treats a wide range of varicose veins in the GSV system, including:

• Tortuous (twisted) veins

• Veins above and below the knee

• Veins with small, medium, and large diameters

• Veins previously treated with other methods

Varithena® is a registered trademark of Provensis Ltd, a BTG International group company.

Precision VIR – Committed to Helping Patients Lead Normal Lives

Precision VIR has long been at the forefront of performing leading-edge procedures to treat vein disease such as varicose veins, spider veins, deep vein thrombosis (DVT), chronic venous insufficiency (CVI), and peripheral arterial disease/peripheral vascular disease (PAD/PVD)—all while providing compassionate patient care.

With multiple locations in the Dallas-Fort Worth area, Precision VIR was established in 2012 as the first independent Vascular and Interventional Radiology practice in North Texas. They focus only on minimally-invasive procedures and surgeries that are the safest and most efficient options for patients. There are no large incisions, which allows for a reduction in risk, less pain, and shorter recovery time.

All physicians at Precision VIR are Board Certified Diagnostic Radiologists with additional Fellowship training in Vascular and Interventional Radiology. Precision VIR serves Dallas, Fort Worth, Carrollton, Richardson, Garland, Mesquite, Highland Park, University Park, Park Cities, Plano, Frisco, Allen, McKinney, Flower Mound, Lewisville, Denton, Arlington, Irving, Grand Prairie and all of North Texas. Precision VIR doctors are area leaders in vascular disease diagnosis and treatment for conditions such as varicose veins, spider veins, deep vein thrombosis (DVT), chronic venous insufficiency (CVI), peripheral arterial disease/peripheral vascular disease (PAD/PVD), IVC filters, women’s pelvic congestion syndrome, male varicoceles and female uterine fibroids.

For more information on Varithena, visit the Precision VIR FAQ page or to see if this procedure is the right treatment for your varicose veins, schedule a consultation by calling (214) 382-3200.

– end –

###

Contact Info:
Name: Shauna Robinson or Madison Horan
Email: info@precisionvir.com
Organization: Precision VIR
Address: 12400 Coit Road, Suite 505, Dallas, TX 75251, United States
Phone: +1-214-382-3200

For more information, please visit https://www.precisionvir.com/vein-care-dallas/

Source: PressCable

Release ID: 331770

More News From Money - The World Insiders

Kushner plans to build twin-towers in New Jersey unraveling

Apr 24, 2018

NEW YORK — First, Jared Kushner's big plans for a skyscraper in Manhattan fell apart. Now, it's the turn of his major twin-tower project across the river in New Jersey. Plans for a pair of gleaming, 66-story residential towers in Jersey City championed by Kushner when he was CEO of his family company are in danger of collapsing amid a heated exchange of letters and emails with the city. The Kushner Cos. is now making veiled threats of legal action. It is saying the heavily Democratic city, run by Mayor Steven Fulop, ended negotiations over the project for no good...

US stocks wobble and bond yields set four-year highs

Apr 24, 2018

NEW YORK — U.S. stocks couldn't hang on to an early gain and finished mostly lower Monday as technology companies slipped. Bond prices continue to fall and the yield on the 10-year Treasury note drew closer to 3 percent, a milestone it hasn't reached since January 2014. Investors once again focused on corporate deals Monday as utility company Vectren agreed to be bought by CenterPoint Energy for $6 billion, while the CEO of Sears called for the company to sell more assets and health care products company Henry Schein said it will split off its animal health unit. Aluminum producers...

Markets Right Now: Stocks end lower after early gain fades

Apr 24, 2018

NEW YORK — The latest on developments in financial markets (all times local): 4 p.m. Stocks are closing mostly lower on Wall Street after an early gain faded away. Technology companies fell Monday, offsetting gains in other sectors including energy and phone companies. Bond prices continue to fall, sending the yield on the 10-year Treasury note closer to 3 percent, a milestone it hasn't reached since January 2014. Sears rose 7.6 percent after the company's CEO said the struggling retailer should sell its Kenmore brand. The S&P 500 index ended little changed at 2,670. The Dow Jones industrial average fell...

AP-NORC Poll: Amid strikes, Americans back teacher raises

Apr 24, 2018

WASHINGTON — Americans overwhelmingly believe teachers don't make enough money, and half say they'd support paying higher taxes to give educators a raise. The findings of the new poll from The Associated Press-NORC Center for Public Affairs Research come amid recent teacher strikes and other protests over low pay, tough classroom conditions and the amount of money allocated to public schools in several Republican-led states. Tens of thousands of Arizona teachers voted last week to strike after rejecting an offer of a 20-percent raise, because it didn't include a vow from state lawmakers not to further cut taxes before providing...

US existing home sales rose 1.1 percent in March

Apr 24, 2018

WASHINGTON — U.S. sales of existing homes increased 1.1 percent on a monthly basis in March, which suggests that buyers are undeterred by the dwindling number of properties available on the market. The National Association of Realtors said Monday that homes sold last month at a seasonally adjusted annual pace of 5.60 million, up from 5.54 million in February. This sales rate is higher than the 2017 total, but March sales were down slightly over the past 12 months. The housing market continues to be in the grip of an inventory crunch that has restricted sales and growth in home...

About Us

The World Insiders brings you exclusive coverage from across the globe in a timely, easy to consume format sourced directly from our regional media partners.

Contact us: sales[at]theworldinsiders.com

Subscribe Now!